Published in Lasers Med Sci on May 24, 2006
Benefits of the use of the CO2 laser in orthodontics. Lasers Med Sci (2007) 0.89
Healing process after surgical treatment with scalpel, electrocautery and laser radiation: histomorphologic and histomorphometric analysis. Lasers Med Sci (2009) 0.88
The Ablation Properties of CO(2) Laser Irradiating to Absorption Media: An In Vitro Study. Int J Dent (2012) 0.75
Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope (1999) 1.26
Progress in determining the malignant potential of oral lesions. J Oral Pathol Med (2003) 1.19
Oral erythroplakia--a review. Oral Oncol (2005) 1.18
Dental factors in the genesis of squamous cell carcinoma of the oral cavity. Oral Oncol (1998) 0.95
Risk factors for oral epithelial dysplasia--the role of smoking and alcohol. Oral Oncol (1999) 0.85
[Zinc and vitamin A deficiency in diseases of the mouth mucosa]. Mund Kiefer Gesichtschir (1998) 0.85
Treatment of developmental defect of upper lip with carbon dioxide laser radiation (CO2): first surgical time. J Cosmet Laser Ther (2005) 0.80
Oral leukoplakia and erythroplakia: a review and update. Pract Periodontics Aesthet Dent (1994) 0.80
Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas J Dermatol (2005) 0.76
Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer (2007) 2.95
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant (2006) 2.44
Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer (2005) 1.94
Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract (2006) 1.84
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2005) 1.23
Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer (2012) 1.23
Evidence that TRPC1 contributes to calcium-induced differentiation of human keratinocytes. Pflugers Arch (2005) 1.02
Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol (2004) 1.00
Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Williston Park) (2003) 0.92
Amifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer (2006) 0.91
The 20 item oral mucositis index: reliability and validity in bone marrow and stem cell transplant patients. Cancer Invest (2002) 0.91
Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.89
Cultured epithelial cells response to phototherapy with low intensity laser. Lasers Surg Med (2007) 0.89
Healing process after surgical treatment with scalpel, electrocautery and laser radiation: histomorphologic and histomorphometric analysis. Lasers Med Sci (2009) 0.88
Managing pain in mucositis. Semin Oncol Nurs (2004) 0.88
Anti-inflammatory agents in the management of alimentary mucositis. Support Care Cancer (2006) 0.87
Evidence that TRPC4 supports the calcium selective I(CRAC)-like current in human gingival keratinocytes. Pflugers Arch (2006) 0.85
CO(2) Laser Surgery and Prosthetic Management for the Treatment of Epulis Fissuratum. ISRN Dent (2010) 0.83
Oral complications and management considerations in patients treated with high-dose chemotherapy. Support Cancer Ther (2004) 0.83
Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease. Biol Blood Marrow Transplant (2006) 0.82
Calcium oscillations in gingival epithelial cells infected with Porphyromonas gingivalis. Microbes Infect (2004) 0.82
Bisphosphonate osteonecrosis (BON): unanswered questions and research possibilities. Rev Recent Clin Trials (2009) 0.81
Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer (2006) 0.80
Molecular identification of an invasive gingival bacterial community. Clin Infect Dis (2005) 0.80
Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support Care Cancer (2014) 0.79
Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls. Support Care Cancer (2006) 0.78
Alimentary mucositis: putting the guidelines into practice. Support Care Cancer (2006) 0.78
Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease. Biol Blood Marrow Transplant (2011) 0.78
Surgical treatment of earlobe keloid with CO2 laser radiation: case report and clinical standpoints. J Cosmet Laser Ther (2008) 0.77
Homogenous amniotic membrane as a biological dressing for oral mucositis in rats: histomorphometric analysis. Arch Oral Biol (2008) 0.77
Oral health in cancer therapy. Tex Dent J (2009) 0.76
Oral health in cancer therapy. Todays FDA (2009) 0.75